Broadcast Date: September 19, 2024
Time: 8:00 am PT, 11:00 am ET, 17:00 CET
Early diagnosis and swift treatment are critical to changing the lung cancer landscape. Aligned with this goal, blood-based testing is a valuable tool to support clinical decision-making from diagnosis through monitoring.
In this webinar, Dr. Gary Pestano will describe current applications of blood-based Droplet Digital™PCR (ddPCR™) testing in the clinic. Among the key takeaways for attendees:
- Case studies that support assay feasibility, development, clinical testing and regulatory approvals from a centralized laboratory.
- Actionable mutations in non-small cell lung cancer (NSCLC) that demonstrate concordance of blood-based testing with tissue, as well as accuracy with orthogonal technologies.
- Robust performance of ddPCR in blood-based monitoring of rare variants at the level of individual patients, clinical trials, and meta-analyses of clinical cohorts.
- Novel applications that enable precision approaches in the clinic.
A live Q&A session will follow the presentations, offering a chance to pose questions to our expert panelist.
